{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:54:04Z","timestamp":1792029244686,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"S4","license":[{"start":{"date-parts":[[2012,5,12]],"date-time":"2012-05-12T00:00:00Z","timestamp":1336780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Spine J"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s00586-012-2337-5","type":"journal-article","created":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T07:15:29Z","timestamp":1336720529000},"page":"587-593","source":"Crossref","is-referenced-by-count":68,"title":["Drug therapy in spinal tuberculosis"],"prefix":"10.1007","volume":"22","author":[{"given":"S.","family":"Rajasekaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Khandelwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,12]]},"reference":[{"key":"2337_CR1","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/j.rmed.2006.08.006","volume":"100","author":"TM Daniel","year":"2006","unstructured":"Daniel TM (2006) The history of tuberculosis. Respir Med 100:1862\u20131870","journal-title":"Respir Med"},{"key":"2337_CR2","doi-asserted-by":"crossref","DOI":"10.5005\/jp\/books\/11046","volume-title":"Tuberculosis of the skeletal system","author":"SM Tuli","year":"2010","unstructured":"Tuli SM (2010) Tuberculosis of the skeletal system, 4th edn. Jaypee Brothers Medical Publishers, New Delhi","edition":"4"},{"key":"2337_CR3","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1001\/jama.293.22.2767","volume":"293","author":"C Dye","year":"2005","unstructured":"Dye C, Watt CJ, Bleed DM et al (2005) Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA 293:2767\u20132775","journal-title":"JAMA"},{"key":"2337_CR4","volume-title":"Classics of orthopaedics","author":"KM Bick","year":"1976","unstructured":"Bick KM (1976) Classics of orthopaedics. JB Lippincott Co., Philadelphia"},{"key":"2337_CR5","unstructured":"Balasubramanian R, Rajeswari R, SanthaT (2004) How does management of extrapulmonary tuberculosis differ from that of pulmonary tuberculosis? In: Toman\u2019s Tuberculosis case detection, monitoring, treatment, 2nd edn. WHO, Geneva"},{"key":"2337_CR6","first-page":"1006","volume-title":"Harrison\u2019s principles of internal medicine","author":"MC Raviglipone","year":"2008","unstructured":"Raviglipone MC, O\u2019Brien RJ (2008) Tuberculosis. In: Fauci AS, Braunwald E, Kasper DL et al (eds) Harrison\u2019s principles of internal medicine. McGraw-Hill, New York, pp 1006\u20131020"},{"key":"2337_CR7","doi-asserted-by":"crossref","unstructured":"Hong Kong Chest Service\/British Medical Research Council (1987) Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Am Rev Respir Dis 136:339\u2013342","DOI":"10.1164\/ajrccm\/136.6.1339"},{"key":"2337_CR8","unstructured":"Controlled trial of 2, 4, and 6\u00a0months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide (1991) Results at 30\u00a0months. Hong Kong Chest Service\/British Medical Research Council. Am Rev Respir Dis 143:700\u2013706"},{"key":"2337_CR9","unstructured":"Toman K (2004) How many drug-resistant tubercle bacilli can be found in the sputum of patients who have never received treatment for tuberculosis? In: Toman\u2019s tuberculosis case detection, monitoring, treatment, 2nd edn. WHO, Geneva"},{"key":"2337_CR10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0041-3879(67)80047-3","volume":"48","author":"F Grumbach","year":"1967","unstructured":"Grumbach F, Canetti G, Grosset J (1967) Late results of long-term intermittent chemotherapy of advanced, murine tuberculosis: limits of the murine model. Tubercle 48:11\u201326","journal-title":"Tubercle"},{"key":"2337_CR11","unstructured":"Lotte A, Hatton F, Perdrizet S, Rouillon A (1964) A concurrent comparison of intermittent (twice-weekly) isoniazid plus streptomycin and daily isoniazid plus PAS in the domiciliary treatment of pulmonary tuberculosis. Bull World Health Organ 31:247\u2013271"},{"key":"2337_CR12","unstructured":"British Thoracic Association (1982) A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24\u00a0months after the end of chemotherapy. Am Rev Respir Dis 126:460\u2013462"},{"key":"2337_CR13","unstructured":"Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis (1978) First report. Am Rev Respir Dis 118:219\u2013228"},{"key":"2337_CR14","doi-asserted-by":"crossref","unstructured":"Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis: the results up to 24\u00a0months (1979) Tubercle 60:201\u2013210","DOI":"10.1016\/0041-3879(79)90001-1"},{"key":"2337_CR15","first-page":"51","volume":"38","author":"R Balasubramanian","year":"1991","unstructured":"Balasubramanian R (1991) Fully intermittent 6\u00a0months regimen for pulmonary tuberculosis in South India. Indian J Tuberc 38:51\u201353","journal-title":"Indian J Tuberc"},{"key":"2337_CR16","unstructured":"Toman K (2004) Toman\u2019s tuberculosis case detection, monitoring, treatment, 2nd edn. WHO, Geneva"},{"key":"2337_CR17","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/jac\/dkg446","volume":"52","author":"Y Zhang","year":"2003","unstructured":"Zhang Y, Wade MM, Scorpio A et al (2003) Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. J Antimicrob Chemother 52:790\u2013795","journal-title":"J Antimicrob Chemother"},{"key":"2337_CR18","unstructured":"World Health Organization (2003) Treatment of Tuberculosis: guidelines for National Programmes. 3rd edn. WHO, Geneva, p 35"},{"key":"2337_CR19","unstructured":"Toman K (2004) How does management of extrapulmonary tuberculosis differs from that of pulmonary tuberculosis? In: Toman\u2019s tuberculosis case detection, monitoring, treatment, 2nd edn. WHO, Geneva"},{"key":"2337_CR20","doi-asserted-by":"crossref","unstructured":"East African\/British Medical Research Councils (1973) Controlled clinical trial of four short course (6-month) regimes of chemotherapy for treatment of pulmonary tuberculosis. Lancet 1:1331\u20131339","DOI":"10.1016\/S0140-6736(73)91671-1"},{"key":"2337_CR21","doi-asserted-by":"crossref","unstructured":"Singapore Tuberculosis Service\/British Medical Research Council (1981) Clinical trial of six-month and four-month regimes of chemotherapy in the treatment of pulmonary tuberculosis: the results up to 30\u00a0months. Tubercle 62:95\u2013102","DOI":"10.1016\/0041-3879(81)90016-7"},{"key":"2337_CR22","unstructured":"Tuberculosis Research Centre (2001) Low rate of emergence of drug resistance in sputum positive patients treated with short course chemotherapy. Int J Tuberc Lung Dis 5:40\u201345"},{"key":"2337_CR23","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1378\/chest.114.5.1239","volume":"114","author":"BL Davidson","year":"1998","unstructured":"Davidson BL (1998) A controlled comparison of directly observed therapy vs self-administered therapy for active tuberculosis in the urban United States. Chest 114:1239\u20131243","journal-title":"Chest"},{"key":"2337_CR24","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJM199404283301702","volume":"330","author":"SE Weis","year":"1994","unstructured":"Weis SE, Slocum P, Blais F et al (1994) The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 330:1179\u20131184","journal-title":"N Engl J Med"},{"key":"2337_CR25","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1164\/ajrccm.154.4.8887600","volume":"154","author":"RD Moore","year":"1996","unstructured":"Moore RD, Chaulk P, Griffiths R et al (1996) Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis. Am J Respir Crit Care Med 154:1013\u20131019","journal-title":"Am J Respir Crit Care Med"},{"key":"2337_CR26","first-page":"3","volume":"54","author":"R Prasad","year":"2007","unstructured":"Prasad R (2007) Management of multi-drug resistant tuberculosis: practitioners view point. Indian J Tuberc 54:3\u201311","journal-title":"Indian J Tuberc"},{"key":"2337_CR27","unstructured":"Almeida D, Mehta A, Rodriques C et al (2002) Comparison of drug resistance of tuberculosis from rural area Sakawar and urban tertiary care centre. In: Presented at 110th general meeting of ASM, Los Angeles, USA, Abstract U58"},{"key":"2337_CR28","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0140-6736(04)15496-2","volume":"363","author":"JS Mukherjee","year":"2004","unstructured":"Mukherjee JS, Rich ML, Socci AR et al (2004) Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet 363:474\u2013481","journal-title":"Lancet"},{"key":"2337_CR29","unstructured":"WHO (2006) Guidelines for the programmatic management of drug resistant tuberculosis. WHO, Geneva"},{"key":"2337_CR30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1302\/0301-620X.82B3.14194","volume":"82","author":"R Lemaire","year":"2000","unstructured":"Lemaire R, Masson B (2000) Risk of transmission of blood-borne viral infection in orthopaedic and trauma surgery. J Bone Joint Surg Br 82:313\u2013323","journal-title":"J Bone Joint Surg Br"},{"key":"2337_CR31","first-page":"S115","volume":"11","author":"MC Raviglione","year":"1997","unstructured":"Raviglione MC, Harries AD, Msiska R et al (1997) Tuberculosis and HIV: current status in Africa. AIDS 11:S115\u2013S123","journal-title":"AIDS"},{"key":"2337_CR32","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/00002030-199408000-00010","volume":"8","author":"K Alwood","year":"1994","unstructured":"Alwood K, Keruly J, Moore-Rice K et al (1994) Effectiveness of supervised, intermittent therapy for tuberculosis in HIV infected patients. AIDS 8:1103\u20131108","journal-title":"AIDS"},{"key":"2337_CR33","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(94)90693-9","volume":"344","author":"A Okwera","year":"1994","unstructured":"Okwera A, Whalen C, Byekwaso F et al (1994) Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans. Lancet 344:1323\u20131328","journal-title":"Lancet"},{"key":"2337_CR34","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1086\/515174","volume":"28","author":"WJ Burman","year":"1999","unstructured":"Burman WJ, Gallicano K, Peloquin C (1999) Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis. Clin Infect Dis 28:419\u2013430","journal-title":"Clin Infect Dis"},{"key":"2337_CR35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1164\/ajrccm.164.1.2101133","volume":"164","author":"WJ Burman","year":"2001","unstructured":"Burman WJ, Jones BE (2001) Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy. Am J Respir Crit Care Med 164:7\u201312","journal-title":"Am J Respir Crit Care Med"},{"key":"2337_CR36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archinte.162.1.97","volume":"162","author":"E Navas","year":"2002","unstructured":"Navas E, Martin-Davila P, Moreno L et al (2002) Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy. Arch Intern Med 162:97\u201399","journal-title":"Arch Intern Med"}],"container-title":["European Spine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-012-2337-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00586-012-2337-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-012-2337-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T15:22:35Z","timestamp":1561735355000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00586-012-2337-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,12]]},"references-count":36,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["2337"],"URL":"https:\/\/doi.org\/10.1007\/s00586-012-2337-5","relation":{},"ISSN":["0940-6719","1432-0932"],"issn-type":[{"value":"0940-6719","type":"print"},{"value":"1432-0932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,12]]}}}